Basic info
Industry
pharmaceutical manufacturing
Sectors
Cutting edge
Biotechnology
Pharmaceutical
Regulatory excellence
GMP
Research
Science
Scar
Immunophysiology
Oral
Drug development
Growth
Gene Therapy
H2020
Uppsala
Biologics
Wound treatment
Skin
IBD
Topical
Health Care
microbiology
Applied microbiology
Immunology
Diabetes
ATMP
Medical
Clinical trials
Date founded
2016
Funding rounds raised
Total raised
$3.6M
from 2 investors over 2 rounds
I
ILYA Pharma raised undisclosed on July 9, 2020
Investors: EIT Health
I
ILYA Pharma raised $3.6M on November 30, 2017
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)